Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients

International Journal of Cancer

Volumn 71, Issue 1, 1997, Pages 31-34

  Okita, Misako ^a,b   Gaudette, Douglas C ^c   Mills, Gordon B ^d   Holub, Bruce J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKEMIA; LIPID COMPOSITION; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; FATTY ACIDS; FEMALE; HUMANS; LEUKEMIA; LYSOPHOSPHATIDYLCHOLINES; MIDDLE AGED; OVARIAN NEOPLASMS; PHOSPHATIDYLCHOLINES;

EID: 0030976523     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4     Document Type: Article

References (30)

1. AMERICAN CANCER SOCIETY, Cancer statistics 1993. CA Cancer J. Clin., 43, 7-26 (1993).
2. 2 in signal transduction through protein kinase C. P roc. nat. Acad. Sci. (Wash.), 89, 6447-6451 (1992).
3. 2 in HL-60 cell differentiation to macrophages induced by protein kinase C activation. Proc. nat. Acad. Sci. (Wash.), 90, 4917-4921 (1993).
4. BAISTED, D.J., ROBINSON, B.S. and VANCE D.E., Albumin stimulates the release of lysophosphatidylcholine from cultured rat hepatocytes. Biochem. J., 253, 693-701 (1988).
5. BUCH, E.G. and DYER, W.J., A rapid method of total lipid extraction and purification. Canad. J. Biochem. Physiol., 37, 911-917 (1959).
6. BUICK, R.N., PULLANO, R. and TRENT, J.M., Comparative properties of five human ovarian carcinoma cell lines. Cancer Res., 45, 3668-3676 (1985).
7. EINHORN, N., SJOVALL, K., KNAPP, R.C., HALL, P., SCULLY, R.E., BAST, R.C. and ZURAWSKI, V.R., Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet. Gynecol. 80, 14-18 (1992).
8. GAUDETTE, D.C., AUKEMA, H.M., JOLLY, C.A., CHAPKIN, R.S. and HOLUB, B.J., Mass and fatty acid composition of the 3-phosphorylated phosphatidylinositol bisphosphate isomer in stimulated human platelets. J. biol Chem., 268, 13773-13776 (1993).
9. GILLET, M.P. and BESTERMAN, E.M., Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases. Atherosclerosis, 22, 111-124 (1975).
10. GRAHAM, A., BENNETT, A.J., MCLEAN, A.M., ZAMMIT, V.A. and BRINDLEY, D.N., Factors regulating the secretion of lysophosphatidylcholine by rat hepatocytes compared with the synthesis and secretion of phosphatidylcholine and triacylglycerol. Biochem. J., 253, 687-692 (1988).
11. HIGASHlYAMA, S., ABRAHAM, J.A., MILLER, J., FIDDES, J.C. and KLAGSBRUN, M., Heparin-bindine growth factor secreted by macrophage-like cells that is related to EGF. Science. 251, 936-939 (1991).
12. KHAN, B.V., PARTHASARATHY, S.S., ALEXANDER, R.W. and MEDFORD, R.M., Modified low density lipoprotein and its constituents augment cytokineactivated vascular cell adhesion molecule-1 eene expression in human vascular endothelial cells. J. clin. Invest., 95, 1262-1270 (1995).
13. KUME, N. and GIMBRONE, M.A., Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. clin. Invest., 93, 907-911 (1993).
14. KRIAT, M., VION-DURY, J., CONFORT-GOUNY, S., FAVRE, R., VIOUT, P., SCIAKY, M., SARI, H. and COZZONE, P.J., Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors. J. Lipid Res., 34, 1009-1019 (1993).
15. 2 activity and plasma lysophosphatidyl- choline levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Amer. Rev. respir. Dis., 142, 157-161 (1990).
16. MOOLENAAR, W.H., JALINK, K. and VAN CORVEN, E.J., Lysophosphatidic acid: a bioactive phospholipid with growth factor-like properties. Rev. Phys. Biochem. Pharmacol. 119, 47-65 (1992).
17. NAKANO, T., RAINES, E.W., ABRAHAM, J.A., KLAGSBRUN, M. and Ross, R., Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human nomocytes. Proc. not. Acad. Sci. (Wash.). 91, 1069-1073 (1994).
18. PHILLIPS, G.B. and DODGE, J.T., Composition of phospholipids and phospholipid fatty acids of human plasma. J. Lipid Res., 8, 676-681 (1967).
19. PORTMAN, O.W., SOLTYS, P., ALEXANDER, M. and OSUGA, T., Metabolism of lysolecithin in vivo: effects of hyperlipemia and atherosclerosis in squirrel monkeys. J. Lipid Res., 11, 596-604 (1970).
20. Ross, R., The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature (Land.), 362, 801-809 (1993).
21. SAIER, E.L., NORDSTRAND, E., JUVES, M.W. and HARTSOCK, R.J., The ratio of free to esterified cholesterol in serum: a new discriminant in correlating lipid metabolism with disease state. Clin. Pathol., 71, 83-87 (1979).
22. SASAKI, Y., ASAOKA, Y. and NISHIZUKA. Y. Potentiation of diacylglycerolinduced activation of protein kinase C by lysophospholipids. FEBS Lett., 320, 47-51 (1993).
23. SCHAPIRA, M.M., MATCHAR, D.B. and YOUNG, M.J., The effectiveness of ovarian cancer screening. Ann. intern. Med., 118, 838-843 (1993).
24. SKEAFF, C.G. and HOLUB, B.J., Effect of dietary fish oil containing eicosapentaenoic acid on the fatty acid composition of platelet phopholipids and on the thrombin-stimulated phopholipid alterations in human platelets. In: M. Lagarde (ed.). Biology of eicosanoids. vol. 152, pp. 63-76, INSERM, Paris (1987).
25. SKIPSKI, V.R. BARCLAY, M., BARCLAY, R.K., FETZER, V.A., GOOD, J.J. and ARCHIBALD, P.M., Lipid composition of human serum lipoproteins. Bioehem. J., 104, 340-352 (1967).
26. STEINBERG, D., PARTHASARATHY, S., CAREW, T.E., KHOO, J.C. and WITZTUM, J.L., Beyond cholesterol: moditications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med., 320, 915-924 (1989).
27. I4C] stearoyl-labelled lysophospholipids in collagenstimulated human platelets. Biochim. biophys. Acta. 1081, 92-98 (1991).
28. TOKUMURA, A., HARADA, K., FUKUZAWA, K. and TSUKATANI, H., Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. biophys. Acta, 875, 31-38 (1986).
29. Xu, Y., GAUDETTE, D.C., BOYNTON, J.D., FRANKEL, A., FANG, X.-J., SHARMA, A., HURTEAU, J., CASEY, G., GOODBODY, A., MELLORS, A., HOLUB, B.J. and MILLS, G.B., Characterization of an ovarian cancer activating factor (OCAF) in ascites from ovarian cancer patients. Clin. Cancer Res., 1, 1223-1232 (1996).
30. YOSHIDA, K., ASAOKA, Y. and NISHIZUKA, Y., Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acids. Proc. not. Acad. Sci. (Wash.), 89, 6443-6446 (1992).